Jane Street’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Jane Street’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,283	Closed	-$54K	–	6377
2019 Q4	$54K	Buy	+16,283	New	+$51.8K	﹤0.01%	4906
2016 Q4	–	Sell	-30,591	Closed	-$283K	–	4847
2016 Q3	$283K	Buy	+30,591	New	+$256K	﹤0.01%	3371

Jane Street's FOMX Position: Q1 2020 in Review

Jane Street sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 16,283 shares — an estimated $54K sold.

Jane Street first reported a position in FOMX in Q3 2016 and held it in 2 quarters. The position peaked at $283K in Q3 2016. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Jane Street reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Jane Street sold 16,283 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $54K.
Jane Street first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2016 and held it in 2 quarters.
Jane Street's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $283K in Q3 2016.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.